CClinicalTrials.gg
RecruitingNCT02918734Updated Jul 20, 2026

Fixation of Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction. Endobutton vs Metal Interference Screws

An interventional study of Endobutton CL BTB and Metal interference screw in Knee Injuries, sponsored by St. Olavs Hospital. Recruiting at 2 sites in Norway. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by St. Olavs Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Oct 2016; still recruiting 10 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

In this randomized controlled trial the investigators will compare the results after primary anterior cruciate ligament (ACL) reconstruction using two different methods for femoral fixation of a bone-patellar tendon-bone (BPTB) autograft. Interference screws have been the standard method for fixing the femoral side of BPTB grafts; however, several pitfalls have been reported. Cortical fixation with the Endobutton CL BTB Fixation System has become available and the clinical results have been described as promising; however, no randomized controlled trials comparing these two femoral fixation methods have been conducted, and there is no published data that confirms that the bone block heals in the tunnel with the newer method.

The aim of our study is to compare the outcome after primary ACL reconstruction with BPTB autografts using the Endobutton CL BTB or metal interference screw for femoral fixation.

Read the detailed description

Primary anterior cruciate ligament (ACL) reconstructions with bone-patellar tendon-bone (BPTB) autografts have recently been found to have a lower risk of revision compared with hamstring tendon autografts, and BPTB has again become our graft of choice. Interference screws have been the standard method for fixing the femoral side of a BPTB graft; however problems such as damage of the graft and failure due to nonparallel screw placement have been reported. Cortical fixation using a suspensory system has been used for soft-tissue graft fixation for several years, and a corresponding device, the Endobutton CL BTB Fixation System (Smith \& Nephew, Inc., Andover, MA, USA), has become available for fixation of bone-tendon-bone grafts. The clinical results after fixation with the Endobutton CL BTB have been described as promising; however, no randomized controlled trials comparing these two fixation methods have been conducted, and there is no published data that confirms that the bone block heals in the tunnel with the newer method.

In this randomized controlled trial, patients undergoing primary ACL reconstruction will be randomized into either an Endobutton group or an interference screw group. The primary aim of the study is to compare these two fixation methods, assessed by patient reported outcomes, laxity, range of motion and muscle strength. Knee related quality of life 2 years after surgery is the primary outcome, measured by the Knee injury and Osteoarthritis Outcome Score (KOOS) subscale "knee related Quality of life (QOL)". Other aims are to see if there is any difference in the integration of the bone block in the femoral tunnel assessed by CT scan, in the risk of developing osteoarthritis assessed by radiographs, or in the risk of a postoperative complication or revision. The patients will be followed up 6 weeks, 6 months, 2 years and 10 years after surgery. CT scan will be performed after 6 months, and radiographs after 2 years and 10 years. In addition details of the rehabilitation will be recorded. Patients undergoing a revision will be followed up but excluded from further comparisons in the study.

Our hypothesis is that there is no difference in the outcome after primary ACL reconstruction with BPTB autografts using the Endobutton CL BTB or metal interference screw for femoral fixation, both with a metal interference screw for the tibial fixation.

02

Conditions studied

  • Knee Injuries

Browse trials for

Keywords

  • Anterior Cruciate Ligament
  • Bone-Patellar Tendon-Bone Grafting
03

In context

Knee Injuries

249 studies on the registry are indexed under Knee Injuries; 48 are open to participants now.

This study's planned enrollment of 220 is above the median of 50 across 160 interventional studies indexed under Knee Injuries.

Browse Knee Injuries studies →

Lead sponsor

St. Olavs Hospital is the lead sponsor of 165 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Primary reconstruction of ACL ruptures
  • Surgery at least 6 weeks after injury
  • The patient must accept and sign the informed consent form before surgery

Exclusion criteria

Exclusion Criteria:

  • Medical indication for using another graft than BPTB autograft (such as history of anterior knee pain or occupations etc. requiring frequent kneeling)
  • Previous major surgical procedures in the same knee
  • Major additional injuries in the knee (posterior cruciate ligament, lateral collateral ligament, medial collateral ligament, sutured meniscus lesions and major cartilage lesions undergoing cartilage repair)
  • Contralateral ACL injury (treated or untreated)
  • Present or former serious illness that makes follow-up or rehabilitation difficult (e.g. alcohol or drug abuse, psychiatric disease)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
220 participants (estimated)

Study arms

  • Experimental
    Endobutton CL BTB

    Femoral fixation of the BPTB autograft with the Endobutton CL BTB Fixation System.

    Device: Endobutton CL BTB

  • Active comparator
    Metal interference screw

    Femoral fixation of the BPTB autograft with a metal interference screw.

    Device: Metal interference screw

Interventions

  • DeviceEndobutton CL BTB

    ACL reconstruction with Endobutton CL BTB

  • DeviceMetal interference screw

    ACL reconstruction with metal interference screw

06

What researchers measure

Primary outcomes

  1. Knee related quality of life

    KOOS subscale "knee related Quality of life (QOL)"

    Time frame: 2 years

Secondary outcomes

  1. Tegner activity scale

    Time frame: 6 months, 2 years, 10 years

  2. Lachman test

    Anterior translation of the tibia

    Time frame: 6 weeks, 6 months, 2 years, 10 years

  3. Muscular strength

    Biodex dynamometer

    Time frame: 6 months, 2 years, 10 years

  4. Bone block integration

    CT scan

    Time frame: 6 months

  5. Osteoarthritis

    X-ray radiographs

    Time frame: 2 years, 10 years

  6. Range of motion

    Time frame: 6 weeks, 6 months, 2 years, 10 years

  7. Knee related quality of life

    KOOS subscale "knee related Quality of life (QOL)"

    Time frame: 6 weeks

  8. Knee related quality of life

    KOOS subscale "knee related Quality of life (QOL)"

    Time frame: 6 months

  9. Knee related quality of life

    KOOS subscale "knee related Quality of life (QOL)"

    Time frame: 10 years

  10. Lysholm functional knee score

    Time frame: 6 weeks, 6 months, 2 years, 10 years

  11. KOOS

    Knee injury and Osteoarthritis Outcome Score

    Time frame: 6 weeks, 6 months, 2 years, 10 years

  12. Pivot shift test

    Anteroposterior and rotational stability

    Time frame: 6 weeks, 6 months, 2 years, 10 years

  13. KT-1000 arthrometer

    Anterior translation of the tibia

    Time frame: 6 weeks, 6 months, 2 years, 10 years

Other outcomes

  1. Complications

    Registration

    Time frame: Up to 10 years

  2. Reoperations

    Registration

    Time frame: Up to 10 years

07

Study locations

2 of 2 sites recruiting
  • Department of Orthopedic Surgery, St Olavs Hospital
    Trondheim, Norway
    Recruiting
  • Rosenborgklinikken
    Trondheim, Norway
    • Agnar Tegnander, md phd · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02918734
Lead sponsor
St. Olavs Hospital
Collaborators
Rosenborgklinikken
Responsible party
Sponsor
First posted
Sep 29, 2016
Start date
Oct 2016
Primary completion
Dec 2026 (estimated)
Completion
Mar 2033 (estimated)
Last update
Jul 20, 2026

Study contacts

Trond Olav Lundemo, md
Contact
TrondOlav.Lundemo@helse-nordtrondelag.no
Tone Gifstad, md phd
Contact
tone.gifstad@stolav.no
Jon Olav Drogset, md phd
principal investigator · St. Olavs Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion